The U.S. Food and Drug Administration is allowing the problem-plagued factory of contract manufacturer Emergent BioSolutions to resume production of COVID-19 vaccine
Related posts
-
Panic Monday: World stock markets plunge again as Trump doubles down on tariffs
Global stock markets extended a severe plunge Monday, fueled by fears that U.S. tariffs would lead... -
Horse rescue charity gets temporary win, as judge blocks sale of farm it rents
A charity that takes care of abused, neglected and unwanted horses won a temporary reprieve from... -
‘I’m alive’: Carol Stream man recalls near-fatal battle with COVID
Carol Stream resident Chuck Drungelo was given a less than 10% chance to survive as he...